Direct versus indirect comparisons: A summary of the evidence

International Journal of Technology Assessment in Health Care

Volumn 24, Issue 2, 2008, Pages 170-177

  Gartlehner, Gerald ^a   Moore, Charity G ^b  

^a DANUBE UNIVERSITY KREMS   (Austria)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Adjusted indirect comparisons; Indirect comparisons; Summary of the evidence

Indexed keywords

ADJUSTED INDIRECT COMPARISONS; INDIRECT COMPARISONS; SUMMARY OF THE EVIDENCE;

LINEAR REGRESSION; STATISTICAL METHODS;

HEALTH CARE;

FLUOXETINE; PLACEBO; PROTON PUMP INHIBITOR; SERTRALINE; VENLAFAXINE;

ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; CLINICAL TRIAL; CONTROLLED STUDY; DECISION MAKING; DIAGNOSTIC VALUE; DIRECT COMPARISON; EVIDENCE BASED PRACTICE; HUMAN; INDIRECT COMPARISON; INTERMETHOD COMPARISON; LOGISTIC REGRESSION ANALYSIS; POPULATION RESEARCH; REGRESSION ANALYSIS; STATISTICAL ANALYSIS; VALIDATION PROCESS; VALIDATION STUDY;

HUMANS; JUDGMENT; MODELS, STATISTICAL; REPRODUCIBILITY OF RESULTS; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 42049113673     PISSN: 02664623     EISSN: 14716348     Source Type: Journal    
DOI: 10.1017/S0266462308080240     Document Type: Article

References (44)

1. Alves C, Cachola I, Brandao J. Efficacy and tolerability of venlafaxine and fluoxetine in outpatientswith major depression. Primary Care Psychiatry. 1999;5:57-63.
2. Baker SG, Kramer BS. The transitive fallacy for randomized trials: If A bests B and B bests C in separate trials, is A better than C? BMC Med Res Methodol. 2002;2:13.
3. Bennie EH, Mullin JM, Martindale JJ. A double-blind multicenter trial comparing sertraline and fluoxetine in outpatients with major depression. J Clin Psychiatry. 1995;56:229-237.
4. Boyer P, Danion JM, Bisserbe JC, et al. Clinical and economic comparison of sertraline and fluoxetine in the treatment of depression. A 6-month double-blind study in a primary-care setting in France. Pharmacoeconomics. 1998;13(pt 2):157-169.
5. Bucher HC, Guyatt GH, Griffith LE, et al. The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. J Clin Epidemiol. 1997;50:683-691.
6. Caldwell DM, Ades AE, Higgins JP. Simultaneous comparison of multiple treatments: Combining direct and indirect evidence. BMJ. 2005;331:897-900.
7. Costa e Silva J. Randomized, double-blind comparison of venlafaxine and fluoxetine in outpatients with major depression. J Clin Psychiatry. 1998;59:352-357.
8. Cunningham LA. Once-daily venlafaxine extended release (XR) and venlafaxine immediate release (IR) in outpatients with major depression. Venlafaxine XR 208 Study Group. Ann Clin Psychiatry. 1997;9:157-164.
9. De Nayer A, Geerts S, Ruelens L, et al. Venlafaxine compared with fluoxetine in outpatients with depression and concomitant anxiety. Int J Neuropsychopharmacol. 2002;5:115-120.
10. Dierick M, Ravizza L, Realini R, et al. A double-blind comparison of venlafaxine and fluoxetine for treatment of major depression in outpatients. Prog Neuropsychopharmacol Biol Psychiatry. 1996;20:57-71.
11. Fava M, Hoog SL, Judge RA, et al. Acute efficacy of fluoxetine versus sertraline and paroxetine inmajor depressive disorder including effects of baseline insomnia. J Clin Psychopharmacol. 2002;22:137-147.
12. Fava M, Judge R, Hoog SL, et al. Fluoxetine versus sertraline and paroxetine in major depressive disorder: Changes in weight with long-term treatment. J Clin Psychiatry. 2000;61:863-867.
13. Glenny AM, Altman DG, Song F, et al. Indirect comparisons of competing interventions. Health Technol Assess. 2005;9:1-148.
14. Gotzsche PC. Lessons from and cautions about noninferiority and equivalence randomized trials. JAMA. 2006;295:1172-1174.
15. Greene WL, Concato J, Feinstein AR. Claims of equivalence in medical research: Are they supported by the evidence? Ann Intern Med. 2000;132:715-722.
16. Higgins JPT, Green S, eds. Cochrane handbook for systematic reviews of interventions. 4.2.5 [updated May 2005]. In: The Cochrane Library, Issue 3, 2005. Chichester, UK: John Wiley & Sons, Ltd.
17. Hypericum Depression Trial Study Group. Effect of Hypericum perforatum (St John's wort) in major depressive disorder: A randomized controlled trial. JAMA. 2002;287:1807-1814.
18. Ioannidis JP. Indirect comparisons: The mesh and mess of clinical trials. Lancet. 2006;368:1470-1472.
19. Khan A, Fabre LF, Rudolph R. Venlafaxine in depressed outpatients. Psychopharmacol Bull. 1991;27:141-144.
20. Kocsis JH, Zisook S, Davidson J, et al. Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: Psychosocial outcomes. Am J Psychiatry. 1997;154:390-395.
21. Kroenke K, West SL, Swindle R, et al. Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care: A randomized trial. JAMA. 2001;286:2947-2955.
22. Lu G, Ades AE. Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med. 2004;23:3105-3124.
23. Lumley T. Network meta-analysis for indirect treatment comparisons. Stat Med. 2002;21:2313-2324.
24. Lydiard RB, Stahl SM, Hertzman M, et al. A double-blind, placebo-controlled study comparing the effects of sertraline versus amitriptyline in the treatment of major depression. J Clin Psychiatry. 1997;58:484-491.
25. McDonagh MS CS. Drug class review on proton pump inhibitors. Drug effectiveness review project 2006. Available at: http://www.ohsu.edu/ drugeffectiveness/reports/documents/PPIs%20Final%Report%u4%Unshaded.pdf. Accessed 11/2/2007.
26. Mehtonen OP, Sogaard J, Roponen P, et al. Randomized, double-blind comparison of venlafaxine and sertraline in outpatients with major depressive disorder. Venlafaxine 631 Study Group. J Clin Psychiatry. 2000;61:95-100.
27. Mendels J, Johnston R, Mattes J, et al. Efficacy and safety of b.i.d. doses of venlafaxine in a dose-response study. Psychopharmacol Bull. 1993;29:169-174.
28. Nemeroff CB, Thase ME. A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients. J Psychiatr Res. 2007;41:351-359.
29. Newhouse PA, Krishnan KR, Doraiswamy PM, et al. A double-blind comparison of sertraline and fluoxetine in depressed elderly outpatients. J Clin Psychiatry. 2000;61:559-568.
30. Olie JP, Gunn KP, Katz E. A double-blind placebo-controlled multicentre study of sertraline in the acute and continuation treatment of major depression. Eur Psychiatry. 1997;12:34-41.
31. Reimherr FW, Byerley WF, Ward MF, et al. Sertraline, a selective inhibitor of serotonin uptake, for the treatment of outpatients with major depressive disorder. Psychopharmacol Bull. 1988;24:200-205.
32. Reimherr FW, Chouinard G, Cohn CK, et al. Antidepressant efficacy of sertraline: A double-blind, placebo- and amitriptyline-controlled, multicenter comparison study in outpatients with major depression. J Clin Psychiatry. 1990;51(Suppl B):18-27.
33. Rudolph RL, Feiger AD. A double-blind, randomized, placebo-controlled trial of once-daily venlafaxine extended release (XR) and fluoxetine for the treatment of depression. J Affect Disord. 1999;56:171-181.
34. Schatzberg A, Roose S. A double-blind, placebo-controlled study of venlafaxine and fluoxetine in geriatric outpatients with major depression. Am J Geriatr Psychiatry. 2006;14:361-370.
35. Schneider LS, Nelson JC, Clary CM, et al. An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression. Am J Psychiatry. 2003;160:1277-1285.
36. Sechter D, Troy S, Paternetti S, et al. A double-blind comparison of sertraline and fluoxetine in the treatment of major depressive episode in outpatients. Eur Psychiatry. 1999;14:41-48.
37. Silverstone PH, Ravindran A. Once-daily venlafaxine extended release (XR) compared with fluoxetine in outpatients with depression and anxiety. Venlafaxine XR 360 Study Group. J Clin Psychiatry. 1999;60:22-28.
38. Sir A, D'Souza RF, Uguz S, et al. Randomized trial of sertraline versus venlafaxine XR in major depression: Efficacy and discontinuation symptoms. J Clin Psychiatry. 2005;66:1312-1320.
39. Song F, Altman DG, Glenny AM, et al. Validity of indirect comparison for estimating efficacy of competing interventions: Empirical evidence from published meta-analyses. BMJ. 2003;326:472.
40. Song F, Glenny AM, Altman DG. Indirect comparison in evaluating relative efficacy illustrated by antimicrobial prophylaxis in colorectal surgery. Control Clin Trials. 2000;21:488-897.
41. Thase ME. Efficacy and tolerability of once-daily venlafaxine extended release (XR) in outpatients with major depression. The Venlafaxine XR 209 Study Group. J Clin Psychiatry. 1997;58:393-398.
42. Tylee A, Beaumont G, Bowden MW, et al. A double-blind, randomized, 12-week comparison study of the safety and efficacy of venlafaxine and fluoxetine in moderate to severe major depression in general practice. Primary Care Psychiatry. 1997;3:51-58.
43. Tzanakaki M, Guazzelli M, Nimatoudis I, et al. Increased remission rates with venlafaxine compared with fluoxetine in hospitalized patients with major depression and melancholia. Int Clin Psychopharmacol. 2000;15:29-34.
44. Van Moffaert M, Bartholome F, Cosyns P, et al. A controlled comparison of sertraline and fluoxetine in acute and continuation treatment of major depression. Hum Psychopharmacol. 1995;10:393-405.